Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.
Carrato A, Paz-Ares Rodríguez L, Rodríguez Lescure A, Casas Fernández de Tejerina AM, Díaz Rubio García E, Pérez Segura P, Constenla Figueiras M, García Carbonero R, Gómez Codina J, Lluch Hernández A, Maroto Rey JP, Martín Jiménez M, Mayordomo Cámara JI, Moreno Nogueira JA, Rueda Domínguez A; Spanish Society of Medical Oncology (SEOM). Carrato A, et al. Among authors: moreno nogueira ja. Clin Transl Oncol. 2009 Jul;11(7):446-54. doi: 10.1007/s12094-009-0383-1. Clin Transl Oncol. 2009. PMID: 19574202
Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007.
de la Haba-Rodríguez J, Alba E, Barnadas A, Bayo E, Llombart A, Lluch A, Martín M, Moreno-Nogueira JA, Pérez Manga G, Rodríguez-Lescure A, Aranda E. de la Haba-Rodríguez J, et al. Among authors: moreno nogueira ja. Clin Transl Oncol. 2008 Sep;10(9):552-9. doi: 10.1007/s12094-008-0250-y. Clin Transl Oncol. 2008. PMID: 18796372
Oncological translational research in the Spanish national health system: the INTRO study.
Caballero C, Jantus-Lewintre E, Carrato A, García-Foncillas J, Gascón P, Blasco A, Moreno-Nogueira JA, Guillem V, López R, Codes M, Antón A, Díaz-Rubio E, Camps C. Caballero C, et al. Among authors: moreno nogueira ja. Clin Transl Oncol. 2014 Aug;16(8):686-95. doi: 10.1007/s12094-013-1138-6. Epub 2013 Dec 5. Clin Transl Oncol. 2014. PMID: 24307394
Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists.
Camps-Herrero C, Paz-Ares L, Codes M, López-López R, Antón-Torres A, Gascón-Vilaplana P, Guillem-Porta V, Carrato A, Cruz-Hernández JJ, Caballero-Díaz C, Blasco-Cordellat A, Moreno-Nogueira JA, Díaz-Rubio E. Camps-Herrero C, et al. Among authors: moreno nogueira ja. Clin Transl Oncol. 2014 Oct;16(10):914-20. doi: 10.1007/s12094-014-1170-1. Epub 2014 Jun 13. Clin Transl Oncol. 2014. PMID: 24924625
[Treatment of indolent non-Hodgkin's lymphomas].
Moreno Nogueira JA, Casas Fernández de Tejerina A, Moreno Rey C. Moreno Nogueira JA, et al. Rev Clin Esp. 2009 Feb;209(2):82-7. doi: 10.1016/s0014-2565(09)70631-9. Rev Clin Esp. 2009. PMID: 19798845 Spanish.
[Safety and efficacy of oral trans-mucosal fentanyl citrate in the long-term treatment of breakthrough pain in oncology patients: the ECODIR study].
Valentín Maganto V, Camps Herrero C, Carulla Torrent J, Cassinello Espinosa J, Dorta Delgado J, Jara Sánchez C, Moreno Nogueira JA. Valentín Maganto V, et al. Among authors: moreno nogueira ja. Clin Transl Oncol. 2005 Jun;7(5):205-12. doi: 10.1007/BF02712818. Clin Transl Oncol. 2005. PMID: 15960932 Clinical Trial. Spanish.
Protein energy malnutrition (PEM) in cancer patients.
Sanz Ortiz J, Moreno Nogueira JA, García de Lorenzo y Mateos A. Sanz Ortiz J, et al. Among authors: moreno nogueira ja. Clin Transl Oncol. 2008 Sep;10(9):579-82. doi: 10.1007/s12094-008-0253-8. Clin Transl Oncol. 2008. PMID: 18796375
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer.
Reina JJ, Aparicio J, Salvador J, Pica JM, Rueda A, Lorenzo A, de la Puente CG, Borrega P, Moreno-Nogueira JA. Reina JJ, et al. Among authors: moreno nogueira ja. Cancer Chemother Pharmacol. 2003 Oct;52(4):339-45. doi: 10.1007/s00280-003-0601-4. Epub 2003 Jul 8. Cancer Chemother Pharmacol. 2003. PMID: 12851783 Clinical Trial.
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study.
Morales S, Lorenzo A, Ramos M, Ballesteros P, Méndez M, Almanza C, Castellanos J, Moreno-Nogueira JA, Casal J, Lizón J, Oltra A, Frau A, Machengs I, Galán A, Belón J, Llorca C. Morales S, et al. Among authors: moreno nogueira ja. Cancer Chemother Pharmacol. 2004 Jan;53(1):75-81. doi: 10.1007/s00280-003-0690-0. Epub 2003 Oct 14. Cancer Chemother Pharmacol. 2004. PMID: 14557896 Clinical Trial.
42 results